On 11-12 February 2020, the WHO, in collaboration with the Global Research Collaboration for Infectious Disease Preparedness and Response (GLOPID-R) – an international network of funders to facilitate coordination and information sharing, organized a Global Forum on research and innovation for COVID-19 (‘Global Research Forum’). [1]
Using the R&D Blueprint strategy as a framework at this forum world scientists assessed “the current level of knowledge about the new virus, agree on critical research questions that need to be answered urgently, and to find ways to work together to accelerate and fund priority research to curtail this outbreak and prepare for those in the future.”
From this the WHO SOLIDARITY trials emerged.